|
1001
|
BCG
|
Pulmonary Tuberculosis (TB)
|
Mycobacterium tuberculosis
|
Live attenuated
|
Organon Teknika Corporation LLC
|
Approved
|
Percutaneous
|
28955344
|
NA
|
|
1002
|
BCG AJV
|
Pulmonary Tuberculosis (TB)
|
Mycobacterium tuberculosis
|
Live attenuated
|
AJ Vaccines
|
Approved
|
Intradermal
|
NA
|
NA
|
|
1236
|
ID93 + GLA-SE
|
Pulmonary Tuberculosis (TB)
|
Mycobacterium tuberculosis
|
Recombinant
|
Quratis Inc.
|
Clinical - Phase 2
|
Intramuscular
|
NA
|
NCT03806686
|
|
1237
|
VPM1002
|
Pulmonary Tuberculosis (TB)
|
Mycobacterium tuberculosis
|
Recombinant
|
Serum Institute of India Pvt. Ltd.
|
Clinical - Phase 2, Phase 3
|
Intradermal
|
NA
|
NCT03152903
|
|
1238
|
TB/FLU-01L
|
Pulmonary Tuberculosis (TB)
|
Mycobacterium tuberculosis
|
Viral vector
|
Research Institute for Biological Safety Problems
|
Clinical - Phase 1
|
Intranasal
|
NA
|
NCT03017378
|
|
1239
|
GX-70
|
Pulmonary Tuberculosis (TB)
|
Mycobacterium tuberculosis
|
DNA vaccine
|
Yonsei University
|
Clinical - Withdrawn
|
Intramuscular
|
NA
|
NCT03159975
|
|
1240
|
Immuvac
|
Pulmonary Tuberculosis (TB)
|
Mycobacterium tuberculosis
|
Inactivated
|
Ministry of Science and Technology
|
Clinical - Phase 3
|
Intradermal
|
NA
|
NCT00265226
|
|
1241
|
H56
|
Pulmonary Tuberculosis (TB)
|
Mycobacterium tuberculosis
|
Subunit
|
Aeras
|
Clinical - Phase 2
|
Intramuscular
|
NA
|
NCT03512249
|
|
1242
|
AERAS-402
|
Pulmonary Tuberculosis (TB)
|
Mycobacterium tuberculosis
|
Viral vector
|
Aeras
|
Clinical - Phase 2
|
Intramuscular
|
26529238
|
NCT02414828
|
|
1243
|
RUTI
|
Pulmonary Tuberculosis (TB)
|
Mycobacterium tuberculosis
|
Inactivated
|
Archivel Farma S.L.
|
Clinical - Phase 2
|
NA
|
NA
|
NCT04919239
|